Intranasal Fentanyl, Midazolam and Dexmedetomidine as Premedication in Pediatric Patients

Veena Chatrath1, Rajan Kumar1, Upasna Sachdeva1

  • 1Department of Anaesthesia, Government Medical College, Amritsar, Punjab, India.

Insights

Intranasal fentanyl and midazolam offer faster sedation for pediatric surgery than dexmedetomidine. Fentanyl excels in induction and IV cannulation, while dexmedetomidine provides superior postoperative sedation.

Area of Science:

  • Pediatric Anesthesiology
  • Pharmacology

Background:

  • Pediatric patients experience significant stress during surgery.
  • Pharmacologic premedication is crucial for managing pediatric anxiety and facilitating anesthesia induction.
  • Limited cognitive abilities in children heighten their susceptibility to surgical stress.

Purpose of the Study:

  • To compare the efficacy of intranasal fentanyl, midazolam, and dexmedetomidine as premedication in pediatric patients.
  • To evaluate the onset of action, anxiolysis, sedation, and procedural outcomes associated with these agents.

Main Methods:

  • Prospective study of 75 pediatric patients (2-6 years, ASA Class I/II).
  • Patients divided into three groups receiving intranasal fentanyl (1.5 μg/kg), midazolam (0.3 mg/kg), or dexmedetomidine (1 μg/kg) 50 minutes pre-surgery.
  • Outcomes assessed included anxiolysis, sedation, child-parent separation, induction quality, IV cannulation, and postoperative sedation.

Main Results:

  • Intranasal fentanyl and midazolam demonstrated earlier onset of anxiolysis and sedation compared to dexmedetomidine.
  • Fentanyl and dexmedetomidine improved child-parent separation and induction quality over midazolam.
  • Fentanyl yielded the best results for intravenous cannulation, while dexmedetomidine provided prolonged postoperative sedation.

Conclusions:

  • Fentanyl and midazolam have a faster onset of action than dexmedetomidine for pediatric premedication.
  • Fentanyl offers superior conditions for surgical induction and emergence.
  • Dexmedetomidine's delayed onset and prolonged action are beneficial for sustained postoperative calmness and sedation.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
264
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
311
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
233
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
301
Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.0K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
274